Hormonal contraception in overweight or obese women
83 results
1 - 83
Hormonal contraception in overweight or obese women - Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2
- Overweight in pregnancy
- Contraception in patients with systemic diseases
- Risk of ischaemic stroke in persons with migraine without aura using combined hormonal contraception
- Abnormal menstrual bleeding
- Contraception: initiation, choice of method and follow-up
- Breast cancer and hormonal contraceptives
- Hormonal contraception
- 20 mcg versus over 20 mcg estrogen combined oral contraceptives for contraception
- Subdermal implants for contraception
- Combined hormonal versus non-hormonal versus progestin-only contraception in lactation
- Continuous or extended cycle use of combined oral contraceptives
- Oral contraceptives in the treatment of endometriosis
- Combined oral contraceptives for heavy menstrual bleeding
- Risk of venous thrombosis in users of 3rd vs. 2nd generation combined oral contraceptives
- Risk of ischaemic stroke in people with migraine with aura
- Combined oral contraceptives and bone mineral density
- Combination contraceptives: effects on weight
- Oral contraceptives in women with systemic lupus erythematosus
- Risk of venous thromboembolism in users of combined contraceptives
- Acne
- Levonorgestrel intrauterine system vs. other forms of reversible contraceptives
- Premenstrual syndrome (PMS)
- Interventions to improve contraception use
- Bariatric surgery (obesity surgery)
- Oral contraceptives and the risk of ovarian cancer
- Ischaemic stroke and myocardial infarction risk with combined oral contraceptives
- Combined oral contraceptive pills (COCs) for treatment of acne
- Risk of myocardial infarction in users of third generation oral contraceptives
- Progestins for symptomatic treatment of endometriosis
- Combined oral contraceptives for polycystic ovary syndrome
- Dyspareunia in women
- Secondary hypertension
- Intrauterine device
- Altering the time of menstruation
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density
- Adenomyosis
- Gynaecological cancers
- Polycystic ovary syndrome (PCOS)
- Porphyrias
- Antenatal clinics: care and examinations
- Ovarian cancer and hormone replacement therapy
- Hair loss and balding
- Long acting progestin contraceptives and bone mineral density
- Benign gynaecological lesions and tumours
- Vulvovaginitis
- Systemic lupus erythematosus (SLE)
- Female sterilisation
- Progestogen-releasing intrauterine systems for heavy menstrual bleeding
- Raynaud's phenomenon (RP) or white finger disease
- Treatment of epilepsy in adults
- Hypertension: investigations, treatment initiation and non-pharmacological treatment